Spectral AI Receives FDA De Novo Classification for DeepView® System, Enabling Commercial Launch
MDAI has more than doubled off its 52-week low of $1.18 on elevated volume (7.5× avg).
Summary
Spectral AI announced FDA De Novo Classification for its DeepView® System, allowing immediate commercial distribution in the U.S. for burn wound assessment.
Key Events · Product Development and Regulatory · MDAI
-
FDA De Novo Classification Granted
The U.S. Food and Drug Administration (FDA) granted De Novo Classification for the DeepView® System for burn indication.
-
Commercial Distribution Authorized
This classification authorizes Spectral AI to commence commercial distribution activities for the DeepView® System in the United States.
-
Validation of Core Technology
The approval validates the company's proprietary AI algorithm and multispectral imaging technology for assessing burn wound healing potential.
-
Addresses Recent Financial Weakness
This positive regulatory news provides a crucial commercial pathway following the company's reported sharp decline in Q1 2026 revenue and increased cash burn.
Analysis · MDAI · Industrial Applications And Services
The FDA De Novo Classification for the DeepView® System is a pivotal regulatory milestone, authorizing Spectral AI to immediately begin commercial distribution in the U.S. for burn indication. This approval validates the company's core technology and opens a critical revenue pathway, which is especially important given the recent Q1 2026 revenue decline and increased cash burn. This official SEC filing confirms the news reported earlier today.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 39.9% of the 323 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDAI was trading at $2.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $75.3M. The 52-week trading range was $1.18 to $3.21. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.